Literature DB >> 1378880

Localization of group-specific epitopes on the major capsid protein of group A rotavirus.

E Kohli1, L Maurice, J F Vautherot, C Bourgeois, J B Bour, J Cohen, P Pothier.   

Abstract

Chemical cleavage of the VP6 protein of bovine rotavirus showed that VP6-specific monoclonal antibodies (MAbs) reacted with the amino acid sequence between glycine 48 and asparagine 107. Furthermore, three synthetic peptides (amino acids 48 to 64, 60 to 75 and 91 to 108) containing part of this sequence and 22 consecutive overlapping heptapeptides corresponding to the region between amino acids 48 and 75 were analysed for their immunoreactivity using group-specific MAbs. The MAbs recognized peptides 48-64 and/or 60-75, and a set of overlapping heptapeptides located between residues 53 (asparagine) and 67 (glycine), which have two short sequences in common: IRNW (residues 56 to 59), recognized by MAb RV-133, and (NW)NFD (residues 58/60 to 62), recognized by MAbs RV-50, -1026 and -443. These results indicate that the sequence between amino acid residues 48 and 75 is present in one of the immunodominant sites of VP6.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1378880     DOI: 10.1099/0022-1317-73-4-907

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  11 in total

1.  Identification of rotavirus VP6 residues located at the interface with VP2 that are essential for capsid assembly and transcriptase activity.

Authors:  Annie Charpilienne; Jean Lepault; Felix Rey; Jean Cohen
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

2.  Rotavirus glycoprotein NSP4 is a modulator of viral transcription in the infected cell.

Authors:  Lynn S Silvestri; M Alejandra Tortorici; Rodrigo Vasquez-Del Carpio; John T Patton
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

3.  Hsp70 negatively controls rotavirus protein bioavailability in caco-2 cells infected by the rotavirus RF strain.

Authors:  Alexis H Broquet; Christelle Lenoir; Agnès Gardet; Catherine Sapin; Serge Chwetzoff; Anne-Marie Jouniaux; Susana Lopez; Germain Trugnan; Maria Bachelet; Ginette Thomas
Journal:  J Virol       Date:  2006-11-01       Impact factor: 5.103

4.  Inhibition of in vitro reconstitution of rotavirus transcriptionally active particles by anti-VP6 monoclonal antibodies.

Authors:  E Kohli; P Pothier; G Tosser; J Cohen; A M Sandino; E Spencer
Journal:  Arch Virol       Date:  1994       Impact factor: 2.574

5.  CS31A capsule-like antigen as an exposure vector for heterologous antigenic determinants.

Authors:  F Bousquet; C Martin; J P Girardeau; M C Méchin; M Der Vartanian; H Laude; M Contrepois
Journal:  Infect Immun       Date:  1994-06       Impact factor: 3.441

6.  Identification of a Small Molecule That Compromises the Structural Integrity of Viroplasms and Rotavirus Double-Layered Particles.

Authors:  Catherine Eichwald; Giuditta De Lorenzo; Elisabeth M Schraner; Guido Papa; Michela Bollati; Paolo Swuec; Matteo de Rosa; Mario Milani; Eloise Mastrangelo; Mathias Ackermann; Oscar R Burrone; Francesca Arnoldi
Journal:  J Virol       Date:  2018-01-17       Impact factor: 5.103

7.  Sequence analysis of cDNA for the VP6 protein of group A avian rotavirus: a comparison with group A mammalian rotaviruses.

Authors:  H Ito; N Minamoto; I Sasaki; H Goto; M Sugiyama; T Kinjo; S Sugita
Journal:  Arch Virol       Date:  1995       Impact factor: 2.574

8.  Recovery and characterization of a replicase complex in rotavirus-infected cells by using a monoclonal antibody against NSP2.

Authors:  C Aponte; D Poncet; J Cohen
Journal:  J Virol       Date:  1996-02       Impact factor: 5.103

9.  Mapping of antigenic sites on the major inner capsid protein of avian rotavirus using an Escherichia coli expression system.

Authors:  H Ito; N Minamoto; H Goto; T R Luo; M Sugiyama; T Kinjo
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

10.  Human group B rotavirus infections cause severe diarrhea in children and adults in Bangladesh.

Authors:  Takeshi Sanekata; Muzahed Uddin Ahmed; Abdul Kader; Koki Taniguchi; Nobumichi Kobayashi
Journal:  J Clin Microbiol       Date:  2003-05       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.